Illumina Ventures Announces New Partner, Mara Aspinall, Has Joined Its Investment Team
Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.
Company Spotlight – DELFI Diagnostics
DELFI Diagnostics is developing a new generation of liquid biopsies that could advance these applications. Built on a new method called fragmentomics and amplified by machine learning, DELFI’s approach is already showing promise, providing early detection for lung, liver and other cancers, and could provide essential insights to inform precision medicine.
Illumina Ventures to Launch Illumina® Ventures Labs
Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.
Illumina Ventures Announces Strategic New Additions to its Investment Team
Illumina Ventures, a genomics and precision health focused venture firm, today announced additions to its investment team. Abhijit “Ron” Mazumder, PhD, MBA, joins as a Partner and Lisa Alderson, MBA as an Entrepreneur in Residence.